Rising Prevalence of Coronary Heart Disease Coupled with Awareness Further Propels the Global Coronary Stent Market.

The global coronary stent market is anticipated to grow at a considerable CAGR during the forecast period (2021-2027). The key factor to drive the market growth is the increasing prevalence of coronary heart diseases among the population. For instance, according to Heart Foundation in 2019, around 2.4% of people live with coronary heart disease in Australia that accounts for 580,000 people in the country. Also, coronary heart disease is killing an average of one person every 29 minutes that is 50 person per day and further, almost 443 people are hospitalized due to coronary heart diseases every day. 

Browse the full report description Global Coronary Stent Market Size, Share & Trends Analysis Report by Mode of Delivery (Balloon-Expandable Stents, Self-Expanding Stents), By Type (Bare-Metal Stents, Drug-Eluting Stents, and Bioabsorbable Stents), Forecast Period 2021-2027 at https://www.omrglobal.com/industry-reports/coronary-stent-market

Moreover, the market player also contributing significantly to the growth of the market by introducing advanced technology-based coronary stents. For instance, in May 2018, Abbott announced that it received approval from the US FDA for its new generation of company’s XIENCE everolimus-eluting coronary system.  The system is designed to treat the complex blockages that are currently 70% of cases. 

With this approval, the company will be able to provide ways to physicians to deliver stents in the most challenging cases and can unblock the difficult to treat lesions with flexibility. Further, in January 2020, Proximo medical became a partner with CeloNova Biosciences to supply COBRA PzF noncoated coronary stent in the US market. With this partnership, both the companies can leverage their experience, expertise to accelerate the market with the support of its breakthrough technologies such as COBRA PzF noncoated coronary stent. The following stent will also allow physicians to give treatment effectively who may benefit from short one-month dual antiplatelet therapy.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Mode of delivery 

o By Type

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- Abbott Laboratories, Boston Scientific Corp, Biotronik, Medtronic PLC, Becton, Dickinson and Co, Terumo Corp., and others.

Key Questions Addressed by the Report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Coronary Stent Market Report Segment

By Mode of delivery

• Balloon-Expandable Stents
• Self-Expanding Stents

               By Type

• Bare-Metal Stents
• Drug-Eluting Stents
• Bioabsorbable Stents

Global Coronary Stent Market Report Segment by Region